Home › Overweight › New Jersey › Trenton
Overweight clinical trials in Trenton, NJ
4 studies for Overweight are looking for participants at sites in and around Trenton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
RecruitingPhase 2
- Clinical Research of Philadelphia, Pennington · 8 mi away
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RecruitingPhase 2
- Premier Research, Trenton
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RecruitingPhase 4
- Psoriasis Treatment Center of Central New Jersey, East Windsor · 11 mi away
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- Premier Research, Trenton
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL28 studies
- Orlando, FL27 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Atlanta, GA20 studies
- Dallas, TX20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in Trenton
- Breast Cancer10 studies
- Heart Failure7 studies
- Psoriasis7 studies
- Cardiovascular Disease7 studies
- Type 2 Diabetes7 studies
- Obesity6 studies
- Depression4 studies
- Ovarian Cancer4 studies
- High Blood Pressure4 studies
- Colorectal Cancer4 studies
- Non-Small Cell Lung Cancer3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.